跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 121 条关于
“Renée Aguiar-Lucander”
全部
121
临床试验
76
药物
5
机构
8
资讯
32
去年
Hansa Biopharma Appoints Renée Aguiar-Lucander as New CEO, Marking New Growth Phase
去年
Hansa Biopharma Appoints Dr. Richard Philipson as Chief Medical Officer to Lead Next Development Phase
去年
Hansa Biopharma's Imlifidase Enables Gene Therapy Access for Duchenne Patients with Pre-existing Antibodies
9个月前
Hansa Biopharma's Phase 3 Trial for Anti-GBM Disease Fails Primary Endpoint Despite Improved Dialysis-Free Outcomes
去年
Hansa Biopharma Secures $24.3M Funding as IDEFIRIX Sales Surge 76% in Q2 2025
去年
Calliditas Therapeutics Pioneered Novel Endpoint for IgAN Drug Approval
11个月前
Hansa Biopharma Reports Positive Phase III ConfIdeS Trial Results for Highly Sensitized Kidney Transplant Patients
去年
Phase 3 Success: Nefecon Shows Promise in Treating IgA Nephropathy, Filing Planned for Early 2021
去年
Biotech Leadership Shuffle Continues as Industry Navigates Transformation in Q2 2025
去年
Garuda Therapeutics Names Avanish Vellanki as New CEO to Advance Off-the-Shelf Stem Cell Platform
第 1 页,共 4 页
上一页
下一页